ESR1 and breast neoplasm: Increased kinase activity (and in some cases increased expression) was observed in ER+/HER2−/PR− breast tumors compared to tumors that are positive for PR expression, with perturbations in RAS/MAPK and PI3K signaling being mostly responsible for these differences.